Induction of virus‐specific cytotoxic T lymphocytes in vivo by liposome‐entrapped mRNA

@article{Martinon1993InductionOV,
  title={Induction of virus‐specific cytotoxic T lymphocytes in vivo by liposome‐entrapped mRNA},
  author={Fr{\'e}d{\'e}ric Martinon and Sivadasan Krishnan and Gerlinde Lenzen and R{\'e}my Magn{\'e} and Elisabeth Gomard and Jean Gérard Guillet and J. P. Levy and Pierre Meulien},
  journal={European Journal of Immunology},
  year={1993},
  volume={23}
}
The induction of anti‐influenza cytotoxic T lymphocytes (CTL) in vivo by immunizing mice with liposomes containing messenger RNA (mRNA) encoding the influenza virus nucleoprotein (NP) is described. NP mRNA, obtained by in vitro transcription, was encapsulated into simple cholesterol/phosphatidylcholine/phosphatidylserine liposomes by the detergent removal technique. The dependance of the route of mRNA‐liposomes delivery on CTL induction was studied. The CTL induced were identical to those… 
Particle-mediated Intravenous Delivery of Antigen mRNA Results in Strong Antigen-specific T-cell Responses Despite the Induction of Type I Interferon
TLDR
Intravenous immunization of mice with LMPs containing ovalbumin, human papilloma virus E7, and tyrosinase-related protein-2 mRNA, either combined or separately, elicited strong antigen-specific T-cell responses and question the current notion that type I IFNs hamper particle-mediated mRNA vaccines.
Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines.
TLDR
It is demonstrated that subcutaneous immunization of mice with mRNA encoding the HIV-1 antigen Gag complexed with DOTAP/DOPE elicits antigen-specific, functional T cell responses resulting in specific killing of Gag peptide-pulsed cells and the induction of humoral responses.
Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy.
TLDR
The lipid nanoparticle formulation presented here is a promising vector for mRNA vaccine delivery, one that is capable of inducing a strong cytotoxic T cell response and further optimization, including the incorporation of different adjuvants, will likely enhance the potency of the vaccine.
Generation of CTL responses using Kunjin replicon RNA
TLDR
These studies vindicate the use of the Kunjin replicon as a vector to deliver encoded proteins for the development of cell‐mediated immune responses.
RNA melanoma vaccine: induction of antitumor immunity by human glycoprotein 100 mRNA immunization.
TLDR
These preclinical studies demonstrate that an RNA tumor antigen vaccine strategy has potential application for human cancer treatment and prevention.
Vaccination with messenger RNA (mRNA).
  • S. Pascolo
  • Biology
    Handbook of experimental pharmacology
  • 2008
TLDR
The structure of mRNA, its possible optimizations for immunization purposes, the different methods of delivery used in preclinical studies, and finally the results of clinical trial where mRNA is the active pharmaceutical ingredient of new innovative vaccines are described.
RNA based vaccines.
TLDR
In this article, immune responses developed, interactions between APC and RNA that activate and dictate DC activation, and preliminary studies using RNA in vivo and in vitro to develop protective immunity are discussed.
Vaccination with mRNAs encoding tumor-associated antigens and granulocyte-macrophage colony-stimulating factor efficiently primes CTL responses, but is insufficient to overcome tolerance to a model tumor/self antigen
TLDR
The data from this study suggest that vaccination with TAA mRNA is a simple and effective means of priming antitumor CTL, and that immunogenicity of the vaccine can be augmented by co-delivery of GM-CSF mRNA.
The immunology of DNA vaccines.
TLDR
It is demonstrated that DNA-based immunizations targeting model tumor antigens such as chicken ovalbumin, β-galactosidase, or CEA induce protective immune responses leading to rejection of a subsequent, normally lethal challenge with antigen-expressing tumor cells.
DNA immunization: effects of vehicle and route of administration on the induction of protective antiviral immunity.
TLDR
The value of markers gene expression in predicting the protection induced by a microbial antigen is questionable suggesting that, when evaluating various promoter constructs, marker gene expression may not adequately replace the direct measurement of biological outcomes.
...
...

References

SHOWING 1-10 OF 28 REFERENCES
Efficiency of peptides and lipopeptides for in vivo priming of virus‐specific cytotoxic T cells
TLDR
The requirements for in vivo priming of virus‐specific CTL using lipopeptide suggest that attachment of the lipopePTide to a hydrophobic entity, such as the cell membrane, is responsible for its efficiency.
In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine
TLDR
It is reported that synthetic viral peptides covalently linked to tripalmitoyl-S-glycerylcysteinyl-seryl-serine (P3CSS) can efficiently prime influenza-virus-specific CTL in vivo and are able to induce the same high-affinity CTL as does the infectious virus.
Priming of influenza virus-specific cytotoxic T lymphocytes vivo by short synthetic peptides.
TLDR
There appears to be heterogeneity in the requirement of CD4+ T cell proliferation in CTL generation, and one possibility is that virus infected cells can stimulate higher affinity T cells that are less helper T cell dependent.
Fine specificity of cytotoxic T lymphocytes primed in vivo either with virus or synthetic lipopeptide vaccine or primed in vitro with peptide
TLDR
Two in vivo primed CTL types efficiently recognized the natural viral nonapeptide NP 366-374 presented by virus-infected H-2b cells, whereas the in vitro primed C TL failed to do so.
Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide.
  • W. Kast, L. Roux, C. Melief
  • Biology
    Proceedings of the National Academy of Sciences of the United States of America
  • 1991
TLDR
By subcutaneous immunization, this peptide induced Sendai virus and NP peptide-specific CTL memory responses in vivo, indicating that viral peptides can be used as antiviral T-cell vaccines.
Peptide-induced antiviral protection by cytotoxic T cells.
TLDR
A specific antiviral cytotoxic immune response in vivo could be induced by the subcutaneous injection of the T-cell epitope of the lymphocytic choriomeningitis virus as an unmodified free synthetic peptide emulsified in incomplete Freund's adjuvant, rendering mice into a LCMV-specific protective state.
Recruitment of alloreactive cytotoxic T lymphocytes by an antigenic peptide
TLDR
It is argued that high epitope density achieved by high peptide concentrations can in vitro recruit lymphocytes of another specificity as well as raise CTL from naive animals by repeated in vitro stimulation with high concentrations of peptide.
In vivo cytotoxic T lymphocyte induction with soluble proteins administered in liposomes.
TLDR
The liposome approach may not only prove a convenient means of inducing CTL responses in vivo but may also be useful to study the mechanisms of Ag processing.
Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. Immune response of BALB/c mice to human immunodeficiency virus envelope glycoprotein.
TLDR
It is shown that a single lipopeptidic construct can induce a total immune response, which is of importance in vaccine development, and is also efficient at stimulating antibody-mediated responses.
Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs
TLDR
It is shown that a single subcutaneous immunization in mice with immunostimulating complexes containing either purified intact gploO envelope glycoprotein of the human immunodeficiency virus (HIV)-l or influenza haemagglutinin results in reproducible and long-lasting priming of HIV specific or influenza-specific CD8+, MHC class I restricted CTL.
...
...